Clinical Trial: Linzhi Jianghuang Fufang Huoxue Anshen Capsule for Non-alcoholic Fatty Liver

U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07637006) titled 'Linzhi Jianghuang Fufang Huoxue Anshen Capsule for Non-alcoholic Fatty Liver' on May 28.

Brief Summary: This is a randomized, double-blinded, placebo-controlled clinical trial aimed at evaluating the efficacy and safety of Linzhi Jianghuang Fufang Huoxue Anshen Capsule (LJF) for non-alcoholic fatty liver.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)

Intervention: DRUG: Linzhi Jianghuang Fufang Huoxue Anshen Capsule (LJF)

Linzhi Jianghuang Fufang Huoxue Anshen Capsule (LJF) is composed of five herbs (e.g., Salviae Miltiorrhizae Radix et Rhizoma...